Parkinson's Disease
Conditions
Interventions
Non-exposed group:Parkinson's Disease Medications
Exposure group:Parkinson's Disease Medications + Electroacupuncture
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1)Patients who meet the International Parkinson and Movement Disorder Society (MDS-PD) clinical diagnostic criteria for Parkinson's Disease (2015).2)Patients with constipation spontaneous sweating nocturia etc. that appeared or worsened after the onset of Parkinson's Disease-related symptoms.3)Age = 40 years and = 80 years no gender restrictions.4)Patients currently undergoing anti-Parkinson's disease conventional medication treatment with stable drug dosages for at least 2 weeks.5)Patients who voluntarily participate in this study and provide informed consent.
Exclusion criteria
Exclusion criteria: 1)Patients with secondary Parkinson's Disease (including those caused by vascular inflammatory toxic drug-induced traumatic hydrocephalus or neoplastic factors) and patients with Parkinson-plus syndromes (including Multiple System Atrophy Progressive Supranuclear Palsy Corticobasal Degeneration Lewy Body Dementia etc.).2)Patients currently suffering from severe life-threatening diseases such as serious cardiovascular cerebrovascular or hematopoietic system diseases or malignant tumors.3)Patients with a past or current diagnosis of psychotic disorders such as schizophrenia or severe depression or those with severe cognitive dysfunction (Mini-Mental State Examination MMSE = 17 points).4)Patients who cannot undergo acupuncture treatment due to skin conditions or limb deformities in the acupoint areas selected for this study.5)Patients who have participated in or are currently participating in other clinical trials within 30 days (1 month) prior to enrollment.6)Patients who have taken antidepressant analgesic or antihistamine medications affecting PD symptoms within 3 weeks prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unified Parkinson Disease Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nocturia episodes over 7 days;Parkinson's Disease Sleep Scale - Revised;Time and Steps Required for a 20-Meter Walk;Self-Rating Anxiety Scale;Hyperhidrosis Disease Severity Scale;39-item Parkinson Disease Question;Adverse Event;Parkinson's Disease Symptom Elements Scale;Visual Analog Scale (VAS) for Sweating Severity;Bowel Movement Diary;Non-Motor Symptoms Scale for Parkinson's Disease;Mini-Mental State Examination;Self-rating depression scale;Chronic Constipation Severity Scale;Schwab and England Activities of Daily Living Scale;Revised Hoehn and Yahr Staging;Epworth Sleepiness Scale;sleep diary;Bristol Stool Form Scale;Parkinson's Disease Medication Usage; | — |
Countries
China
Contacts
Public ContactZhaoqin Wang
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed